found that SARS‐CoV‐2 infection induced a significant increase in TF activity on the surface of circulating EVs in vivo, and that this activity correlated with disease severity and may be associated with thrombosis in COVID‐19 patients (Rosell et al., 2021). The gene discussed is TF; the disease is deep vein thrombosis.